133 related articles for article (PubMed ID: 10894990)
1. Contribution of PET studies in diagnosis of corticobasal degeneration.
Lutte I; Laterre C; Bodart JM; De Volder A
Eur Neurol; 2000; 44(1):12-21. PubMed ID: 10894990
[TBL] [Abstract][Full Text] [Related]
2. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
[TBL] [Abstract][Full Text] [Related]
3. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Nagasawa H; Tanji H; Nomura H; Saito H; Itoyama Y; Kimura I; Tuji S; Fujiwara T; Iwata R; Itoh M; Ido T
J Neurol Sci; 1996 Aug; 139(2):210-7. PubMed ID: 8856655
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of glucose metabolism in corticobasal degeneration.
Taniwaki T; Yamada T; Yoshida T; Sasaki M; Kuwabara Y; Nakagawa M; Mihara F; Motomura S; Shigetou H; Kira J
J Neurol Sci; 1998 Nov; 161(1):70-6. PubMed ID: 9879684
[TBL] [Abstract][Full Text] [Related]
5. Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis.
Galardi G; Perani D; Grassi F; Bressi S; Amadio S; Antoni M; Comi GC; Canal N; Fazio F
Acta Neurol Scand; 1996 Sep; 94(3):172-6. PubMed ID: 8899050
[TBL] [Abstract][Full Text] [Related]
6. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
Blin J; Vidailhet MJ; Pillon B; Dubois B; Feve JR; Agid Y
Mov Disord; 1992 Oct; 7(4):348-54. PubMed ID: 1484530
[TBL] [Abstract][Full Text] [Related]
7. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
[TBL] [Abstract][Full Text] [Related]
8. Cerebral blood flow correlates of higher brain dysfunctions in corticobasal degeneration.
Okuda B; Tachibana H; Kawabata K; Takeda M; Sugita M
J Geriatr Psychiatry Neurol; 1999; 12(4):189-93. PubMed ID: 10616866
[TBL] [Abstract][Full Text] [Related]
9. [Corticobasal degeneration: a combined clinical, PET and pathological study].
Sato M; Nagata K; Yokoyama E; Hirata Y
Rinsho Shinkeigaku; 1996 Feb; 36(2):293-9. PubMed ID: 8752683
[TBL] [Abstract][Full Text] [Related]
10. Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration.
Tetzloff KA; Duffy JR; Strand EA; Machulda MM; Boland SM; Utianski RL; Botha H; Senjem ML; Schwarz CG; Josephs KA; Whitwell JL
Neurocase; 2018 Apr; 24(2):111-120. PubMed ID: 29799310
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.
Hu WT; Rippon GW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Josephs KA
Mov Disord; 2009 Jul; 24(9):1375-9. PubMed ID: 19425061
[TBL] [Abstract][Full Text] [Related]
12. Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
Hirato M; Horikoshi S; Kawashima Y; Satake K; Shibazaki T; Ohye C
Adv Neurol; 1993; 60():511-4. PubMed ID: 8420180
[No Abstract] [Full Text] [Related]
13. Corticobasal degeneration: key emerging issues.
Ali F; Josephs KA
J Neurol; 2018 Feb; 265(2):439-445. PubMed ID: 29063240
[TBL] [Abstract][Full Text] [Related]
14. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration.
Laureys S; Salmon E; Garraux G; Peigneux P; Lemaire C; Degueldre C; Franck G
J Neurol; 1999 Dec; 246(12):1151-8. PubMed ID: 10653307
[TBL] [Abstract][Full Text] [Related]
15. Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome.
Mille E; Levin J; Brendel M; Zach C; Barthel H; Sabri O; Bötzel K; Bartenstein P; Danek A; Rominger A
J Neuroimaging; 2017 Mar; 27(2):255-261. PubMed ID: 27572945
[TBL] [Abstract][Full Text] [Related]
16. Voxel-wise analysis of diffusion tensor MRI improves the confidence of diagnosis of corticobasal degeneration non-invasively.
Bozzali M; Cercignani M; Baglio F; Scotti G; Farina E; Pugnetti L; Ashburner J; Nemni R; Falini A
Parkinsonism Relat Disord; 2008; 14(5):436-9. PubMed ID: 18328770
[TBL] [Abstract][Full Text] [Related]
17. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.
Juh R; Pae CU; Kim TS; Lee CU; Choe B; Suh T
Neurosci Lett; 2005 Jul 22-29; 383(1-2):22-7. PubMed ID: 15936506
[TBL] [Abstract][Full Text] [Related]
18. [Corticobasal degeneration].
Mizusawa H
Rinsho Shinkeigaku; 1997 Dec; 37(12):1131-3. PubMed ID: 9577668
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
Klaffke S; Kuhn AA; Plotkin M; Amthauer H; Harnack D; Felix R; Kupsch A
Mov Disord; 2006 Oct; 21(10):1724-7. PubMed ID: 16773621
[TBL] [Abstract][Full Text] [Related]
20. Cortical metabolism in posterolateral thalamic stroke: PET study.
Chabriat H; Pappata S; Levasseur M; Fiorelli M; Tran Dinh S; Baron JC
Acta Neurol Scand; 1992 Sep; 86(3):285-90. PubMed ID: 1414249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
